Previous investigations of the effects of HDAC inhibitors on cancer cells have included exploration of the impact of these inhibitors on the expression of MHC class I molecules, and in several instances positive effects have been noted [e.g., 18, 19, 26, 27]. This evidence concerns the gene HDAC9 and cancer.